← All organizations

Highest phase reached
Phase 3
Timeline
2000s
- Jun 1, 2006
MC2 Therapeutics— Founded
2020s
- Jul 20, 2020
betamethasone— NDA Secondary Org
Drugs by trial phase (7 distinct, 9 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Marketed drugs (2)
Recent trials (9)
- NCT06132919Lead sponsorPhase 2Oct 11, 2023
- NCT05482698Lead sponsorPhase 2Jul 1, 2022
- NCT03892564Lead sponsorPhase 1Feb 27, 2019
- NCT03899064Lead sponsorPhase 1Feb 13, 2019
- NCT03819218Lead sponsorPhase 2Dec 27, 2018
- NCT03802344Lead sponsorPhase 3Dec 12, 2018
- NCT03758365Lead sponsorPhase 1Nov 5, 2018
- NCT03462927Lead sponsorPhase 2Feb 8, 2018
- NCT03308799Lead sponsorPhase 3Oct 3, 2017
Details
- Founded
- Horsholm, DK Jun 1, 2006
- Last known activity
- Oct 11, 2023